Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.50
Ask: 1.60
Change: -0.10 (-6.06%)
Spread: 0.10 (6.667%)
Open: 1.65
High: 1.565
Low: 1.475
Prev. Close: 1.65
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Shield Therapeutics Replaces Founder

Wed, 22nd Apr 2020 15:13

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday, Tuesday and Wednesday and not separately reported by Alliance News:

----------

Shield Therapeutics PLC - pharmaceuticals - Tim Watts promoted to chief executive officer from chief financial officer, replacing the company's founder, Carl Sterritt. Shield said Sterritt, who formed the company in 2008, resigned "following discussions with major shareholders and with mutual agreement". Watts has been CFO since August 2018, previously having served in the same role at Oxford BioMedica PLC. Watts also worked at AstraZeneca PLC for 22 years.

----------

Bunzl PLC - distributor - Hires Vin Murria as non-executive director, starting June 1. Was founder & chief executive officer of Advanced Computer Software Group PLC. She is currently a non-executive director at Softcat PLC, DWF Group PLC and finnCap Group PLC.

----------

Mobile Streams PLC - data analytics platform - Peter Tomlinson resigns as director immediately, having been with the company for 20 years. Tomlinson stepped in as chair of Mobile Streams at the start of 2018, handing over to Nigel Burton late last year as the company raised equity following a vote by shareholders against delisting the company from AIM. Mobile Streams said Wednesday that Tomlinson "took over as chairman during a difficult time and supported the transition to a new management team".

----------

Metro Bank PLC - Gene Lockhart and Stuart Bernau step down as non-executive directors from May 18, replaced by Anne Grim, Ian Henderson, and Nicholas Winsor. Grim was chief customer officer for fund manager Fidelity International Ltd, and also worked for lenders Barclays PLC and Wells Fargo & Co. Henderson is CEO of Australian know-your-customer service provider Kyckr. Prior that he was chief operating officer for private banking businesses at Barclays Wealth and CEO of RBS International at Royal Bank of Scotland Group PLC. Winsor was CEO of several HSBC Holdings PLC businesses. Metro Bank noted its board now will consist of eight independent non-executive directors and two executive directors.

----------

Centrica PLC - Carlos Pascual and Steve Pusey will step down as non-executive directors from the annual general meeting on May 22.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
27 Sep 2021 14:17

EXECUTIVE CHANGES: Bank of Ireland CFO leaves; EMIS names new non-exec

EXECUTIVE CHANGES: Bank of Ireland CFO leaves; EMIS names new non-exec

Read more
17 Aug 2021 12:00

Shield Therapeutics swings to losses in first half

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics reported first-half revenues of £0.5m in its interim results on Tuesday, falling from £8.9m year-on-year.

Read more
17 Aug 2021 11:23

AIM WINNERS & LOSERS: Sunrise results good; Surface gets brake deal

AIM WINNERS & LOSERS: Sunrise results good; Surface gets brake deal

Read more
17 Aug 2021 10:57

Shield Therapeutics shares fall as swings to loss in first half

Shield Therapeutics shares fall as swings to loss in first half

Read more
12 Aug 2021 19:25

TRADING UPDATES: Corcel buys Wo Wo Gap project; Amiad, UDG leave LSE

TRADING UPDATES: Corcel buys Wo Wo Gap project; Amiad, UDG leave LSE

Read more
12 Aug 2021 12:25

Shield Therapeutics inks exclusive licence for 'Accrufer' in Korea

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics has entered into an exclusive licence agreement for 'Accrufer', it announced on Thursday, with Korea Pharma in South Korea.

Read more
9 Aug 2021 17:08

TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million

TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million

Read more
24 Jun 2021 19:56

TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook

TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook

Read more
18 Jun 2021 15:39

EXECUTIVE CHANGES: Trident Royalties picks ex-Glencore member as chair

EXECUTIVE CHANGES: Trident Royalties picks ex-Glencore member as chair

Read more
10 Jun 2021 16:12

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
28 May 2021 15:48

EXECUTIVE CHANGES: Mitchells & Butlers slims board following fundraise

EXECUTIVE CHANGES: Mitchells & Butlers slims board following fundraise

Read more
28 May 2021 13:37

Shield Therapeutics appoints industry veteran Greg Madison as CEO

(Sharecast News) - Commercial stage pharmaceutical company Shield Therapeutics announced on Friday that Greg Madison has been appointed as its chief executive officer, with effect from 1 June.

Read more
24 May 2021 14:44

IN BRIEF: SPAC TECC Capital looks to list on Aquis Stock Exchange

IN BRIEF: SPAC TECC Capital looks to list on Aquis Stock Exchange

Read more
21 May 2021 17:51

TRADING UPDATES: Arkle spots gold; SDCL seals USD177 million buy

TRADING UPDATES: Arkle spots gold; SDCL seals USD177 million buy

Read more
18 May 2021 19:15

TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls

TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.